334 related articles for article (PubMed ID: 25462364)
1. Urine analysis concerning xenon for doping control purposes.
Thevis M; Piper T; Geyer H; Schaefer MS; Schneemann J; Kienbaum P; Schänzer W
Rapid Commun Mass Spectrom; 2015 Jan; 29(1):61-6. PubMed ID: 25462364
[TBL] [Abstract][Full Text] [Related]
2. Measuring xenon in human plasma and blood by gas chromatography/mass spectrometry.
Thevis M; Piper T; Geyer H; Thomas A; Schaefer MS; Kienbaum P; Schänzer W
Rapid Commun Mass Spectrom; 2014 Jul; 28(13):1501-6. PubMed ID: 24861600
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous detection of xenon and krypton in equine plasma by gas chromatography-tandem mass spectrometry for doping control.
Kwok WH; Choi TL; So PK; Yao ZP; Wan TS
Drug Test Anal; 2017 Feb; 9(2):317-322. PubMed ID: 27001214
[TBL] [Abstract][Full Text] [Related]
4. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.
Thomas A; Geyer H; Kamber M; Schänzer W; Thevis M
J Mass Spectrom; 2008 Jul; 43(7):908-15. PubMed ID: 18563864
[TBL] [Abstract][Full Text] [Related]
6. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls.
Sigmund G; Dib J; Tretzel L; Piper T; Bosse C; Schänzer W; Thevis M
Drug Test Anal; 2015; 7(11-12):1057-62. PubMed ID: 26481102
[TBL] [Abstract][Full Text] [Related]
7. Isotope-dilution mass spectrometric quantification of the prodrug lisdexamfetamine in human urine in doping control analysis.
Thevis M; Sigmund G; Thomas A; Vogel M; Walpurgis K; Kwiatkowska D; Geyer H; Schänzer W
Rapid Commun Mass Spectrom; 2014 Apr; 28(7):781-6. PubMed ID: 24573809
[TBL] [Abstract][Full Text] [Related]
8. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches.
Sigmund G; Koch A; Orlovius AK; Guddat S; Thomas A; Schänzer W; Thevis M
Drug Test Anal; 2014; 6(11-12):1197-205. PubMed ID: 24913825
[TBL] [Abstract][Full Text] [Related]
9. Doping control analysis of trenbolone and related compounds using liquid chromatography-tandem mass spectrometry.
Thevis M; Guddat S; Schänzer W
Steroids; 2009 Mar; 74(3):315-21. PubMed ID: 19007801
[TBL] [Abstract][Full Text] [Related]
10. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
Schänzer W; Guddat S; Thomas A; Opfermann G; Geyer H; Thevis M
Drug Test Anal; 2013; 5(11-12):810-8. PubMed ID: 23873860
[TBL] [Abstract][Full Text] [Related]
11. Doping control analysis of methoxyphenamine using liquid chromatography-tandem mass spectrometry.
Thevis M; Sigmund G; Koch A; Guddat S; Maurer HH; Schänzer W
Eur J Mass Spectrom (Chichester); 2008; 14(3):145-52. PubMed ID: 18708694
[TBL] [Abstract][Full Text] [Related]
12. Determination of Vasopressin and Desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes.
Thomas A; Solymos E; Schänzer W; Baume N; Saugy M; Dellanna F; Thevis M
Anal Chim Acta; 2011 Nov; 707(1-2):107-13. PubMed ID: 22027126
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of urinary glycerol levels for doping control purposes using gas chromatography-mass spectrometry.
Thevis M; Guddat S; Flenker U; Schänzer W
Eur J Mass Spectrom (Chichester); 2008; 14(3):117-25. PubMed ID: 18708691
[TBL] [Abstract][Full Text] [Related]
15. Doping control analysis of desmopressin in human urine by LC-ESI-MS/MS after urine delipidation.
Esposito S; Deventer K; T'Sjoen G; Vantilborgh A; Van Eenoo P
Biomed Chromatogr; 2013 Feb; 27(2):240-5. PubMed ID: 22740500
[TBL] [Abstract][Full Text] [Related]
16. Detection in urine of 4-methyl-2-hexaneamine, a doping agent.
Perrenoud L; Saugy M; Saudan C
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3767-70. PubMed ID: 19800302
[TBL] [Abstract][Full Text] [Related]
17. Comparison of gas chromatography/quadrupole time-of-flight and quadrupole Orbitrap mass spectrometry in anti-doping analysis: I. Detection of anabolic-androgenic steroids.
Abushareeda W; Tienstra M; Lommen A; Blokland M; Sterk S; Kraiem S; Horvatovich P; Nielen M; Al-Maadheed M; Georgakopoulos C
Rapid Commun Mass Spectrom; 2018 Dec; 32(23):2055-2064. PubMed ID: 30216576
[TBL] [Abstract][Full Text] [Related]
18. Detection of Stimulants and Narcotics by Liquid Chromatography-Tandem Mass Spectrometry and Gas Chromatography-Mass Spectrometry for Sports Doping Control.
Ahrens BD; Kucherova Y; Butch AW
Methods Mol Biol; 2016; 1383():247-63. PubMed ID: 26660193
[TBL] [Abstract][Full Text] [Related]
19. Screening for two selective androgen receptor modulators using gas chromatography-mass spectrometry in doping control analysis.
Thevis M; Kohler M; Schlörer N; Fusshöller G; Schänzer W
Eur J Mass Spectrom (Chichester); 2008; 14(3):153-61. PubMed ID: 18708695
[TBL] [Abstract][Full Text] [Related]
20. Xenon elimination kinetics following brief exposure.
Schaefer MS; Piper T; Geyer H; Schneemann J; Neukirchen M; Thevis M; Kienbaum P
Drug Test Anal; 2017 May; 9(5):666-670. PubMed ID: 27341380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
